CRISPR stories
Drug discovery teams can now outsource industrial-scale CRISPR screening in human cells as the Cambridge biotech expands its service offer.
New Zealand artificial intelligence expert Michael Witbrock warns rapid advancements in AI could significantly displace all human jobs within the next 10 years.
New rules in the EU could leave New Zealand growers outbid in export markets unless Parliament loosens gene-editing restrictions soon.
.webp)
